Am J Transplant, Volume 22, Suppl 3 Archives - Page 12 of 190 - ATC Abstracts

2022 American Transplant Congress
Pediatric Kidney Transplant Delays Due To Respiratory Viruses: A Provider Survey
T. A. Heald-Sargent¹, S. Manz², T. Barton³, P. Verghese⁴
¹Pediatric Infectious Diseases, Lurie Children's Hospital/Northwestern University, Chicago, IL, ²Central Michigan University, Mount Pleasant, MI, ³Pediatric Infectious Diseases, UT Health San Antonoio, San Antonio, TX, ⁴Pediatric Nephrology, Lurie Children's Hospital/Northwestern University, Chicago, IL
*Purpose: This study aimed to characterize the management and impact of respiratory viral infections on pediatric kidney transplantation waitlisted candidates.*Methods: An IRB-approved, anonymous REDCap survey…
2022 American Transplant Congress
Changes in Cold Ischemia Time and Transplantation Practices with the Concentric Model of Kidney Allocation
C. M. Puttarajappa¹, P. Sood¹, A. Tevar¹, V. Gunabushanam¹, S. Hariharan¹, S. Mohan²
¹University of Pittsburgh Medical Center, Pittsburgh, PA, ²Columbia University, New York, NY
*Purpose: Evaluate impact of the new concentric kidney allocation system (KAS250) on kidney utilization, allocation practices and cold ischemia time (CIT).*Methods: Using data from the…
2022 American Transplant Congress
Validation of the PROMIS® Medication Adherence Scale Among Kidney Transplant Recipients on Tacrolimus
J. D. Peipert¹, R. Slay², B. Smith², D. Cella¹, A. Keys², D. Taber²
¹Northwestern University, Chicago, IL, ²Medical University of South Carolina, Charleston, SC
*Purpose: Kidney transplant recipients (KTR) take a daily regimen of immunosuppression medication that almost inevitably includes tacrolimus (TAC). Non-adherence to TAC is a strong predictor…
2022 American Transplant Congress
Differentially Methylated Genes Predict Post-Transplant Relapse of Unresectable Hepatoblastoma
M. Ningappa¹, M. Muarya², C. Ashokkumar¹, H. Hakonarson³, S. Subramaniam⁴, R. Sindhi¹
¹Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ²Department of Bioengineering & San Diego Supercomputer Center, University of California, San Diego, CA, ³Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴Department of Computer Science and Engineering, and Nanoengineering, University of California, San Diego, La Jolla, CA
*Purpose: Hepatoblastoma (HB), a developmental liver tumor of childhood requires liver transplantation (LT) if it remains unresectable despite chemotherapy. Post-transplant relapse in up to 20%…
2022 American Transplant Congress
Cmv-Specific Cell-Mediated Immune Reconstitution in High-Risk Hematopoietic Cell Transplant Recipients Receiving Letermovir Prophylaxis
M. Z. Abidi¹, K. Garth¹, J. Gutman², A. Weinberg¹
¹Medicine, Infectious Disease, University of Colorado, Aurora, CO, ²Medicine, Hematology and Oncology, University of Colorado, Aurora, CO
*Purpose: In the absence of antiviral prophylaxis following Hematopoietic Cell Transplant (HCT), the incidence of clinically significant cytomegalovirus reactivation (cCMV) is 30% in CMV seropositive…
2022 American Transplant Congress
Social Determinants of Health Impact Successful Listing for Liver and Kidney Transplant
J. B. Henson, D. Mohottige, J. M. Wilder, A. J. Muir, L. M. McElroy
Duke University, Durham, NC
*Purpose: To evaluate the association between community socioeconomic disadvantage and structural social determinants of health (SDOH) on successful listing for liver (LT) and kidney transplantation…
2022 American Transplant Congress
Presence of Infiltrating Regulatory T Cells in the Cardiac Xenografts and Their Potential Role in Graft Survival
A. K. Singh¹, C. E. Goerlich¹, G. Braileanu¹, A. Hershfeld¹, T. Zhang¹, I. Tatarov¹, B. Lewis¹, F. Sentz¹, D. Ayares², B. Griffith¹, M. M. Mohiuddin¹
¹Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, ²Revivicor Inc, Blacksburg, WV
*Purpose: Regulatory T (CD4+CD25HiFoxP3+) cells (Treg) are a very small subset of CD4+ T cells that have been shown to play an important role in…
2022 American Transplant Congress
Early Clinical Experience With Nirmatrelvir/ritonavir For Treatment Of Covid-19 In Solid Organ Transplant Recipients
D. Salerno¹, D. Jennings², N. Lange³, D. Kovac¹, T. Shertel¹, J. Chen⁴, J. Hedvat⁵, J. Scheffert¹, R. S. Brown⁶, M. Pereira⁷
¹NewYork-Presbyterian Hospital, New York, NY, ²Long Island University, Brooklyn, NY, ³Pharmacy, NewYork-Presbyterian Hospital, New York, NY, ⁴Columbia University Irving Medical Center, Fort Lee, NJ, ⁵New York Presbyterian Hospital, Tenafly, NJ, ⁶Weill Cornell Medicine, New York, NY, ⁷New York Presbyterian Hospital, New York, NY
*Purpose: Nirmatrelvir/ritonavir use has not yet been described in solid organ transplant recipients (SOTR) who become infected with COVID-19. The objective of our study was…
2022 American Transplant Congress
Non-HLA Antibodies to G Protein-Coupled Receptors and Allograft Survival in Pediatric Kidney Transplant Recipients: Short- and Long-Term Outcomes
M. Pearl¹, L. Chen¹, P. Weng¹, E. T. Chambers², E. F. Reed³
¹UCLA, Los Angeles, CA, ²Pediatrics, Duke University, Durham, NC, ³Univ of California LA, Los Angeles, CA
*Purpose: We have recently shown that the non-HLA antibodies to angiotensin II type 1 receptor (AT1R-Ab) and endothelin-1 type A receptor (ETAR-Ab) are prevalent and…
2022 American Transplant Congress
Kidney Transplant Alone Recipients with Advanced Liver Disease Have Similar Outcomes to Those without Advanced Liver Disease
R. R. Nathani, S. M. Rutledge, C. Villarroel, R. Shapiro, G. Y. Im
Icahn School of Medicine at Mount Sinai, New York, NY
*Purpose: The prevalence of concomitant liver disease (CLD) in patients with ESRD is reported to be 7-40%. Safety of kidney transplant alone (KTA) in those…